{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:38:33Z","timestamp":1791873513515,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000001","name":"Alberta Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Apoptosis is fundamental to normal animal development and is the target for many anticancer therapies. Recent studies have explored the consequences of \u201cfailed apoptosis\u201d where the apoptotic program is initiated but does not go to completion and does not cause cell death. Nevertheless, this failed apoptosis induces DNA double-strand breaks generating mutations that facilitate tumorigenesis. Whether failed apoptosis is relevant to clinical disease is unknown. BCL-2 interacting killer (BIK) is a stress-induced BH3-only protein that stimulates apoptosis in response to hormone and growth factor deprivation, hypoxia, and genomic stress. It was unclear whether BIK promotes or suppresses tumor survival within the context of breast cancer. We investigated this and show that BIK induces failed apoptosis with limited caspase activation and genomic damage in the absence of extensive cell death. Surviving cells acquire aggressive phenotypes characterized by enrichment of cancer stem-like cells, increased motility and increased clonogenic survival. Furthermore, by examining six independent cohorts of patients (total <jats:italic>n<\/jats:italic>\u2009=\u2009969), we discovered that high BIK mRNA and protein levels predicted clinical relapse of Estrogen receptor (ER)-positive cancers, which account for almost 70% of all breast cancers diagnosed but had no predictive value for hormone receptor-negative (triple-negative) patients. Thus, this study identifies BIK as a biomarker for tumor recurrence of ER-positive patients and provides a potential mechanism whereby failed apoptosis contributes to cancer aggression.<\/jats:p>","DOI":"10.1038\/s41419-020-2654-2","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T09:02:42Z","timestamp":1591866162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Vrajesh","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Maringa","family":"Githaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-2960","authenticated-orcid":false,"given":"Richard","family":"Veldhoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Hugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambasivarao","family":"Damaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing Swie","family":"Goping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"2654_CR1","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.3874430","volume":"228","author":"Y Tsujimoto","year":"1985","unstructured":"Tsujimoto, Y., Cossman, J., Jaffe, E. & Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440\u20131443 (1985).","journal-title":"Science"},{"key":"2654_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/335440a0","volume":"335","author":"DL Vaux","year":"1988","unstructured":"Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440\u2013442 (1988).","journal-title":"Nature"},{"key":"2654_CR3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1535-7163.MCT-13-0058","volume":"12","author":"C Billard","year":"2013","unstructured":"Billard, C. BH3 mimetics: status of the field and new developments. Mol. Cancer Ther. 12, 1691\u20131700 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"2654_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/cdd.2015.50","volume":"22","author":"AR Delbridge","year":"2015","unstructured":"Delbridge, A. R. & Strasser, A. The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ. 22, 1071\u20131080 (2015).","journal-title":"Cell Death Differ."},{"key":"2654_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1513257","volume":"374","author":"AW Roberts","year":"2016","unstructured":"Roberts, A. W. et al. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 374, 311\u2013322 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2654_CR6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1296::AID-CNCR12>3.0.CO;2-1","volume":"82","author":"MD Berardo","year":"1998","unstructured":"Berardo, M. D. et al. bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 82, 1296\u20131302 (1998).","journal-title":"Cancer"},{"key":"2654_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molonc.2008.01.004","volume":"2","author":"LM Vargas-Roig","year":"2008","unstructured":"Vargas-Roig, L. M. et al. Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy. Mol. Oncol. 2, 102\u2013111 (2008).","journal-title":"Mol. Oncol."},{"key":"2654_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10549-006-9183-2","volume":"99","author":"A Neri","year":"2006","unstructured":"Neri, A. et al. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer. Breast Cancer Res. Treat. 99, 77\u201383 (2006).","journal-title":"Breast Cancer Res. Treat."},{"key":"2654_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrc.2016.58","volume":"16","author":"G Ichim","year":"2016","unstructured":"Ichim, G. & Tait, S. W. A fate worse than death: apoptosis as an oncogenic process. Nat. Rev. Cancer 16, 539\u2013548 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"2654_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","volume":"57","author":"G Ichim","year":"2015","unstructured":"Ichim, G. et al. Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol. Cell 57, 860\u2013872 (2015).","journal-title":"Mol. Cell"},{"key":"2654_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.molcel.2015.03.003","volume":"58","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Caspase-3 promotes genetic instability and carcinogenesis. Mol. Cell 58, 284\u2013296 (2015).","journal-title":"Mol. Cell"},{"key":"2654_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.454","volume":"8","author":"MA Miles","year":"2017","unstructured":"Miles, M. A. & Hawkins, C. J. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell Death Dis. 8, e3062 (2017).","journal-title":"Cell Death Dis."},{"key":"2654_CR13","doi-asserted-by":"publisher","unstructured":"Cartwright, I. M., Liu, X., Zhou, M., Li, F. & Li, C. Y. Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis. elife https:\/\/doi.org\/10.7554\/eLife.26371 (2017).","DOI":"10.7554\/eLife.26371"},{"key":"2654_CR14","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/febs.13970","volume":"284","author":"BD Larsen","year":"2017","unstructured":"Larsen, B. D. & Sorensen, C. S. The caspase-activated DNase: apoptosis and beyond. FEBS J. 284, 1160\u20131170 (2017).","journal-title":"FEBS J."},{"key":"2654_CR15","doi-asserted-by":"publisher","first-page":"33272","DOI":"10.18632\/oncotarget.8924","volume":"7","author":"V Pandya","year":"2016","unstructured":"Pandya, V. et al. The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer. Oncotarget 7, 33272\u201333285 (2016).","journal-title":"Oncotarget"},{"key":"2654_CR16","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1073\/pnas.0307337101","volume":"101","author":"J Hur","year":"2004","unstructured":"Hur, J. et al. The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proc. Natl Acad. Sci. USA 101, 2351\u20132356 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2654_CR17","doi-asserted-by":"publisher","first-page":"10153","DOI":"10.1158\/0008-5472.CAN-05-3696","volume":"66","author":"J Hur","year":"2006","unstructured":"Hur, J. et al. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. Cancer Res. 66, 10153\u201310161 (2006).","journal-title":"Cancer Res."},{"key":"2654_CR18","doi-asserted-by":"publisher","first-page":"13994","DOI":"10.1073\/pnas.2235866100","volume":"100","author":"KR Coser","year":"2003","unstructured":"Coser, K. R. et al. Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7\/BUS breast cancer cells by DNA microarray. Proc. Natl Acad. Sci. USA 100, 13994\u201313999 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2654_CR19","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/onc.2009.40","volume":"27","author":"G Chinnadurai","year":"2008","unstructured":"Chinnadurai, G., Vijayalingam, S. & Rashmi, R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 27, S20\u2013S29 (2008).","journal-title":"Oncogene"},{"key":"2654_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/cdd.2008.183","volume":"16","author":"LC Spender","year":"2009","unstructured":"Spender, L. C. et al. TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ. 16, 593\u2013602 (2009).","journal-title":"Cell Death Differ."},{"key":"2654_CR21","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1016\/j.febslet.2006.08.088","volume":"580","author":"PJ Real","year":"2006","unstructured":"Real, P. J. et al. Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells. FEBS Lett. 580, 5905\u20135909 (2006).","journal-title":"FEBS Lett."},{"key":"2654_CR22","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2009.13","volume":"16","author":"A Ritchie","year":"2009","unstructured":"Ritchie, A., Gutierrez, O. & Fernandez-Luna, J. L. PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts. Cell Death Differ. 16, 838\u2013846 (2009).","journal-title":"Cell Death Differ."},{"key":"2654_CR23","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/sj.bjc.6605981","volume":"103","author":"L Bodet","year":"2010","unstructured":"Bodet, L. et al. BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma. Br. J. Cancer 103, 1808\u20131814 (2010).","journal-title":"Br. J. Cancer"},{"key":"2654_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1083\/jcb.200801186","volume":"183","author":"YA Mebratu","year":"2008","unstructured":"Mebratu, Y. A., Dickey, B. F., Evans, C. & Tesfaigzi, Y. The BH3-only protein Bik\/Blk\/Nbk inhibits nuclear translocation of activated ERK1\/2 to mediate IFNgamma-induced cell death. J. Cell Biol. 183, 429\u2013439 (2008).","journal-title":"J. Cell Biol."},{"key":"2654_CR25","first-page":"883","volume":"60","author":"AC Koong","year":"2000","unstructured":"Koong, A. C. et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60, 883\u2013887 (2000).","journal-title":"Cancer Res."},{"key":"2654_CR26","first-page":"1474","volume":"7","author":"S Kagawa","year":"2001","unstructured":"Kagawa, S. et al. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin. Cancer Res. 7, 1474\u20131480 (2001).","journal-title":"Clin. Cancer Res."},{"key":"2654_CR27","doi-asserted-by":"publisher","first-page":"23829","DOI":"10.1074\/jbc.M500800200","volume":"280","author":"JP Mathai","year":"2005","unstructured":"Mathai, J. P., Germain, M. & Shore, G. C. BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J. Biol. Chem. 280, 23829\u201323836 (2005).","journal-title":"J. Biol. Chem."},{"key":"2654_CR28","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.emboj.7600592","volume":"24","author":"M Germain","year":"2005","unstructured":"Germain, M., Mathai, J. P., McBride, H. M. & Shore, G. C. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J. 24, 1546\u20131556 (2005).","journal-title":"EMBO J."},{"key":"2654_CR29","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00018-013-1555-2","volume":"71","author":"S Solier","year":"2014","unstructured":"Solier, S. & Pommier, Y. The nuclear gamma-H2AX apoptotic ring: implications for cancers and autoimmune diseases. Cell Mol. Life Sci. 71, 2289\u20132297 (2014).","journal-title":"Cell Mol. Life Sci."},{"key":"2654_CR30","doi-asserted-by":"publisher","first-page":"24494","DOI":"10.1074\/jbc.272.39.24494","volume":"272","author":"B Elangovan","year":"1997","unstructured":"Elangovan, B. & Chinnadurai, G. Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J. Biol. Chem. 272, 24494\u201324498 (1997).","journal-title":"J. Biol. Chem."},{"key":"2654_CR31","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1158\/0008-5472.CAN-06-4594","volume":"67","author":"Y Fu","year":"2007","unstructured":"Fu, Y., Li, J. & Lee, A. S. GRP78\/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 67, 3734\u20133740 (2007).","journal-title":"Cancer Res."},{"key":"2654_CR32","doi-asserted-by":"publisher","first-page":"25687","DOI":"10.1074\/jbc.M110.212944","volume":"286","author":"H Zhou","year":"2011","unstructured":"Zhou, H., Zhang, Y., Fu, Y., Chan, L. & Lee, A. S. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). J. Biol. Chem. 286, 25687\u201325696 (2011).","journal-title":"J. Biol. Chem."},{"key":"2654_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/bjc.2012.105","volume":"107","author":"A Dubrovska","year":"2012","unstructured":"Dubrovska, A. et al. CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling. Br. J. Cancer 107, 43\u201352 (2012).","journal-title":"Br. J. Cancer"},{"key":"2654_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep39782","volume":"7","author":"C Morata-Tarifa","year":"2017","unstructured":"Morata-Tarifa, C. et al. Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity. Sci. Rep. 7, 39782 (2017).","journal-title":"Sci. Rep."},{"key":"2654_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","volume":"16","author":"L Zhang","year":"2017","unstructured":"Zhang, L., Xu, L., Zhang, F. & Vlashi, E. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle 16, 737\u2013745 (2017).","journal-title":"Cell Cycle"},{"key":"2654_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.18632\/oncotarget.1459","volume":"5","author":"AF Vieira","year":"2014","unstructured":"Vieira, A. F. et al. P-cadherin signals through the laminin receptor alpha6beta4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. Oncotarget 5, 679\u2013692 (2014).","journal-title":"Oncotarget"},{"key":"2654_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2106","volume":"10","author":"MJ Grimshaw","year":"2008","unstructured":"Grimshaw, M. J. et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 10, R52 (2008).","journal-title":"Breast Cancer Res."},{"key":"2654_CR38","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/bjc.2014.105","volume":"110","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Lack of correlation of stem cell markers in breast cancer stem cells. Br. J. Cancer 110, 2063\u20132071 (2014).","journal-title":"Br. J. Cancer"},{"key":"2654_CR39","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.yexcr.2008.03.008","volume":"314","author":"G Rappa","year":"2008","unstructured":"Rappa, G. et al. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp. Cell Res. 314, 2110\u20132122 (2008).","journal-title":"Exp. Cell Res."},{"key":"2654_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jsbmb.2014.10.016","volume":"148","author":"J Wahler","year":"2015","unstructured":"Wahler, J. et al. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer. J. Steroid Biochem. Mol. Biol. 148, 148\u2013155 (2015).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2654_CR41","first-page":"829","volume":"6","author":"R Wang","year":"2014","unstructured":"Wang, R. et al. Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors. J. Thorac. Dis. 6, 829\u2013837 (2014).","journal-title":"J. Thorac. Dis."},{"key":"2654_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou, C. et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J. Natl Cancer Inst. 98, 262\u2013272 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"2654_CR43","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1200\/JCO.2010.28.4273","volume":"28","author":"WF Symmans","year":"2010","unstructured":"Symmans, W. F. et al. Genomic index of sensitivity to endocrine therapy for breast cancer. J. Clin. Oncol. 28, 4111\u20134119 (2010).","journal-title":"J. Clin. Oncol."},{"key":"2654_CR44","doi-asserted-by":"publisher","first-page":"e45831","DOI":"10.1371\/journal.pone.0045831","volume":"7","author":"WH Kuo","year":"2012","unstructured":"Kuo, W. H. et al. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas. PLoS ONE 7, e45831 (2012).","journal-title":"PLoS ONE"},{"key":"2654_CR45","doi-asserted-by":"publisher","first-page":"e0122333","DOI":"10.1371\/journal.pone.0122333","volume":"10","author":"S Maubant","year":"2015","unstructured":"Maubant, S. et al. Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells. PLoS ONE 10, e0122333 (2015).","journal-title":"PLoS ONE"},{"key":"2654_CR46","doi-asserted-by":"publisher","first-page":"e63712","DOI":"10.1371\/journal.pone.0063712","volume":"8","author":"V Maire","year":"2013","unstructured":"Maire, V. et al. TTK\/hMPS1 is an attractive therapeutic target for triple-negative breast cancer. PLoS ONE 8, e63712 (2013).","journal-title":"PLoS ONE"},{"key":"2654_CR47","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/0008-5472.CAN-12-2633","volume":"73","author":"V Maire","year":"2013","unstructured":"Maire, V. et al. Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer. Cancer Res. 73, 813\u2013823 (2013).","journal-title":"Cancer Res."},{"key":"2654_CR48","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey, L. A. et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295, 2492\u20132502 (2006).","journal-title":"JAMA"},{"key":"2654_CR49","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.breast.2013.07.005","volume":"22","author":"P Bertheau","year":"2013","unstructured":"Bertheau, P. et al. p53 in breast cancer subtypes and new insights into response to chemotherapy. Breast 22, S27\u2013S29 (2013).","journal-title":"Breast"},{"key":"2654_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3035","volume":"13","author":"A Rody","year":"2011","unstructured":"Rody, A. et al. A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res. 13, R97 (2011).","journal-title":"Breast Cancer Res."},{"key":"2654_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11010-008-9718-4","volume":"312","author":"X Zhao","year":"2008","unstructured":"Zhao, X. et al. The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca2+ stores. Mol. Cell Biochem. 312, 33\u201338 (2008).","journal-title":"Mol. Cell Biochem."},{"key":"2654_CR52","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1038\/sj.onc.1208890","volume":"24","author":"M Oppermann","year":"2005","unstructured":"Oppermann, M. et al. Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk\/Bik. Oncogene 24, 7369\u20137380 (2005).","journal-title":"Oncogene"},{"key":"2654_CR53","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1089\/104303403767740777","volume":"14","author":"U Naumann","year":"2003","unstructured":"Naumann, U. et al. Adenoviral natural born killer gene therapy for malignant glioma. Hum. Gene Ther. 14, 1235\u20131246 (2003).","journal-title":"Hum. Gene Ther."},{"key":"2654_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00975-w","volume":"8","author":"YA Mebratu","year":"2017","unstructured":"Mebratu, Y. A. et al. Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria. Nat. Commun. 8, 803 (2017).","journal-title":"Nat. Commun."},{"key":"2654_CR55","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1038\/sj.onc.1205340","volume":"21","author":"JP Mathai","year":"2002","unstructured":"Mathai, J. P., Germain, M., Marcellus, R. C. & Shore, G. C. Induction and endoplasmic reticulum location of BIK\/NBK in response to apoptotic signaling by E1A and p53. Oncogene 21, 2534\u20132544 (2002).","journal-title":"Oncogene"},{"key":"2654_CR56","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/sj.onc.1210783","volume":"27","author":"R Rashmi","year":"2008","unstructured":"Rashmi, R., Pillai, S. G., Vijayalingam, S., Ryerse, J. & Chinnadurai, G. BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene 27, 1366\u20131375 (2008).","journal-title":"Oncogene"},{"key":"2654_CR57","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1083\/jcb.200703040","volume":"179","author":"B Gillissen","year":"2007","unstructured":"Gillissen, B. et al. Mcl-1 determines the Bax dependency of Nbk\/Bik-induced apoptosis. J. Cell Biol. 179, 701\u2013715 (2007).","journal-title":"J. Cell Biol."},{"key":"2654_CR58","first-page":"533","volume":"8","author":"SH Meterissian","year":"2001","unstructured":"Meterissian, S. H. et al. Bcl-2 is a useful prognostic marker in Dukes\u2032 B colon cancer. Ann. Surg. Oncol. 8, 533\u2013537 (2001).","journal-title":"Ann. Surg. Oncol."},{"key":"2654_CR59","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/cdd.2013.16","volume":"20","author":"S Biswas","year":"2013","unstructured":"Biswas, S., Shi, Q., Wernick, A., Aiello, A. & Zinkel, S. S. The loss of the BH3-only Bcl-2 family member Bid delays T-cell leukemogenesis in Atm-\/- mice. Cell Death Differ. 20, 869\u2013877 (2013).","journal-title":"Cell Death Differ."},{"key":"2654_CR60","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1101\/gad.1940210","volume":"24","author":"V Labi","year":"2010","unstructured":"Labi, V. et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev. 24, 1602\u20131607 (2010).","journal-title":"Genes Dev."},{"key":"2654_CR61","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1101\/gad.1940110","volume":"24","author":"EM Michalak","year":"2010","unstructured":"Michalak, E. M. et al. Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev. 24, 1608\u20131613 (2010).","journal-title":"Genes Dev."},{"key":"2654_CR62","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S0748-7983(03)00138-0","volume":"29","author":"M Tomita","year":"2003","unstructured":"Tomita, M. et al. Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer. Eur. J. Surg. Oncol. 29, 654\u2013657 (2003).","journal-title":"Eur. J. Surg. Oncol."},{"key":"2654_CR63","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1083\/jcb.201706134","volume":"216","author":"G Sun","year":"2017","unstructured":"Sun, G. et al. A molecular signature for anastasis, recovery from the brink of apoptotic cell death. J. Cell Biol. 216, 3355\u20133368 (2017).","journal-title":"J. Cell Biol."},{"key":"2654_CR64","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1091\/mbc.e11-11-0926","volume":"23","author":"HL Tang","year":"2012","unstructured":"Tang, H. L. et al. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol. Biol. Cell 23, 2240\u20132252 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"2654_CR65","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1038\/onc.2010.242","volume":"29","author":"MM Lovric","year":"2010","unstructured":"Lovric, M. M. & Hawkins, C. J. TRAIL treatment provokes mutations in surviving cells. Oncogene 29, 5048\u20135060 (2010).","journal-title":"Oncogene"},{"key":"2654_CR66","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10549-014-2991-x","volume":"146","author":"S Haricharan","year":"2014","unstructured":"Haricharan, S., Bainbridge, M. N., Scheet, P. & Brown, P. H. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data. Breast Cancer Res. Treat. 146, 211\u2013220 (2014).","journal-title":"Breast Cancer Res. Treat."},{"key":"2654_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrc.2017.122","volume":"18","author":"D Soteriou","year":"2018","unstructured":"Soteriou, D. & Fuchs, Y. A matter of life and death: stem cell survival in tissue regeneration and tumour formation. Nat. Rev. Cancer 18, 187\u2013201 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2654_CR68","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nm.2385","volume":"17","author":"Q Huang","year":"2011","unstructured":"Huang, Q. et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med. 17, 860\u2013866 (2011).","journal-title":"Nat. Med."},{"key":"2654_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stem.2010.03.002","volume":"6","author":"T Bondar","year":"2010","unstructured":"Bondar, T. & Medzhitov, R. p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell 6, 309\u2013322 (2010).","journal-title":"Cell Stem Cell"},{"key":"2654_CR70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"2654_CR71","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cub.2014.12.059","volume":"25","author":"CA Ford","year":"2015","unstructured":"Ford, C. A. et al. Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma. Curr. Biol. 25, 577\u2013588 (2015).","journal-title":"Curr. Biol."},{"key":"2654_CR72","doi-asserted-by":"publisher","first-page":"14536","DOI":"10.1073\/pnas.0907560106","volume":"106","author":"KR Coser","year":"2009","unstructured":"Coser, K. R. et al. Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor. Proc. Natl Acad. Sci. USA 106, 14536\u201314541 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2654_CR73","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1242\/jcs.188946","volume":"129","author":"JM Githaka","year":"2016","unstructured":"Githaka, J. M. et al. Ligand-induced growth and compaction of CD36 nanoclusters enriched in Fyn induces Fyn signaling. J. Cell Sci. 129, 4175\u20134189 (2016).","journal-title":"J. Cell Sci."},{"key":"2654_CR74","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","volume":"175","author":"NP Singh","year":"1988","unstructured":"Singh, N. P., McCoy, M. T., Tice, R. R. & Schneider, E. L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184\u2013191 (1988).","journal-title":"Exp. Cell Res."},{"key":"2654_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1383-5718(02)00251-6","volume":"534","author":"K Konca","year":"2003","unstructured":"Konca, K. et al. A cross-platform public domain PC image-analysis program for the comet assay. Mutat. Res. 534, 15\u201320 (2003).","journal-title":"Mutat. Res."},{"key":"2654_CR76","doi-asserted-by":"publisher","unstructured":"Borowicz, S. et al. The soft agar colony formation assay. J. Vis. Exp. https:\/\/doi.org\/10.3791\/51998 (2014).","DOI":"10.3791\/51998"},{"key":"2654_CR77","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837\u2013845 (1988).","journal-title":"Biometrics"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2654-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2654-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2654-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:02:49Z","timestamp":1670252569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2654-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":77,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["2654"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2654-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"448"}}